UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor‐responsive oesophageal eosinophilia is a GERD‐related phenomenon

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (5), p.522-530

2016

Volltextzugriff (PDF)

OC.18.4 CLINICAL AND ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS – DATA FROM A SINGLE TERTIARY ITALIAN CENTER

Digestive and liver disease, 2014-03, Vol.46, p.S39-S40

2014

Volltextzugriff (PDF)

OC.11.2 A PROSPECTIVE STUDY ON CLOSTRIDIUM DIFFICILE INFECTION, TOXINO TYPE AND ANTIBIOTIC SENSITIVITY IN INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S79-S80

2013

Volltextzugriff (PDF)

P.03.12 CMV-SPECIFIC T-CELL RESPONSE IS RETAINED IN IBD PATIENTS UNDERGOING IMMUNOSUPPRESSIVE TREATMENT

Digestive and liver disease, 2013-03, Vol.45, p.S109-S109

2013

Volltextzugriff (PDF)

P.02.8 EARLY PREDICTORS OF LONG TERM CLINICAL RESPONSE TO ADALIMUMAB IN CROHN'S DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S99-S100

2013

Volltextzugriff (PDF)

P.03.14 EVIDENCE OF HCMV-DNA AND MI-RNA-UL112 IN THE INTESTINAL MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S109-S110

2013

Volltextzugriff (PDF)

P.15.8 ASSESSMENT OF BOWEL PREPARATION FOR COLONOSCOPY: COMPARISON BETWEEN DIFFERENT TOOLS AND DIFFERENT HEALTHCARE PROFESSIONALS

Digestive and liver disease, 2013-03, Vol.45, p.S195-S196

2013

Volltextzugriff (PDF)

P.15.9 PRELIMINARY DATA ON SAFETY, EFFICACY AND TOLERABILITY OF BOWEL PREPARATION FOR COLONOSCOPY IN IBD

Digestive and liver disease, 2013-03, Vol.45, p.S196-S196

2013

Volltextzugriff (PDF)

Measuring disease activity in Crohn's disease: what is currently available to the clinician

Clinical and Experimental Gastroenterology, 2014-01, Vol.7 (default), p.151-161

2014

Volltextzugriff (PDF)

P.54 CMV SPECIFIC T-CELL RESPONSE IS CONSERVED IN IBD PATIENTS

Digestive and liver disease, 2010, Vol.42, p.S122-S122

2010

Volltextzugriff (PDF)

P.07.8 MAGNETIZATION TRANSFER IMAGING FOR THE ASSESSMENT OF INTESTINAL FIBROSIS IN CROHN'S DISEASE

Digestive and liver disease, 2019-03, Vol.51, p.e225-e225

2019

Volltextzugriff (PDF)

NON-INVASIVE MARKERS IN THE ASSESSMENT OF CHRONIC DIARRHOEA

Digestive and liver disease, 2009, Vol.41, p.S67-S68

2009

Volltextzugriff (PDF)

P.02.24 EVALUATION OF QUALITY OF LIFE IN IBD PATIENTS TREATED WITH ANTI-TNFA THERAPY

Digestive and liver disease, 2018-03, Vol.50 (2), p.e141-e142

2018

Volltextzugriff (PDF)

DETERMINATION OF 5-ASA AND ITS DERIVATIVES IN THE COLONIC MUCOSA OF ULCERATIVE COLITIS PATIENTS: A SURROGATE MARKER OF OXIDATIVE DAMAGE?

Digestive and liver disease, 2009, Vol.41, p.S137-S138

2009

Volltextzugriff (PDF)

ENROLLMENT IN IBD CLINICAL RESEARCH: THE PATIENT'S POINT OF VIEW

Digestive and liver disease, 2009, Vol.41, p.S166-S166

2009

Volltextzugriff (PDF)

P.07.3 EFFECTIVENESS OF GOLIMUMAB IN REAL LIFE – A SINGLE CENTER PROSPECTIVE STUDY

Digestive and liver disease, 2018-03, Vol.50 (2), p.e193-e194

2018

Volltextzugriff (PDF)

OC.16.5 IMPACT OF ADALIMUMAB'S PATIENT SUPPORT PROGRAM ON ADHERENCE TO ANTI-TNF-ALFA THERAPY IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER ANALYSIS

Digestive and liver disease, 2018-03, Vol.50 (2), p.e110-e110

2018

Volltextzugriff (PDF)

N014 The impact of nursing care on quality of life in IBD patients: A cross-sectional study

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S574-S575

2018

Volltextzugriff (PDF)

N010 Impact of adalimumab’s patient support program on adherence to anti-TNFα therapy in patients with inflammatory bowel disease: A single-centre analysis

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S572-S573

2018

Volltextzugriff (PDF)

Randomized controlled trials in maintenance of remission in Crohn's disease

Reviews on recent clinical trials, 2012-11, Vol.7 (4), p.270

2012

Volltextzugriff (PDF)

P506 Efficacy and safety of two bowel preparations for colonoscopy in IBD patients

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S278-S279

2014

Volltextzugriff (PDF)

P701 Cytomegalovirus-specific T-cell response is conserved in IBD patients

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S292-S292

2013

Volltextzugriff (PDF)

P703 A prospective study on Clostridium difficile infection, toxino type and antibiotic sensitivity in inflammatory bowel disease

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S293-S293

2013

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor‐responsive oesophageal eosinophilia is a GERD‐related phenomenon

OC.18.4 CLINICAL AND ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS – DATA FROM A SINGLE TERTIARY ITALIAN CENTER

OC.11.2 A PROSPECTIVE STUDY ON CLOSTRIDIUM DIFFICILE INFECTION, TOXINO TYPE AND ANTIBIOTIC SENSITIVITY IN INFLAMMATORY BOWEL DISEASE

P.03.12 CMV-SPECIFIC T-CELL RESPONSE IS RETAINED IN IBD PATIENTS UNDERGOING IMMUNOSUPPRESSIVE TREATMENT

P.02.8 EARLY PREDICTORS OF LONG TERM CLINICAL RESPONSE TO ADALIMUMAB IN CROHN'S DISEASE

P.03.14 EVIDENCE OF HCMV-DNA AND MI-RNA-UL112 IN THE INTESTINAL MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

P.15.8 ASSESSMENT OF BOWEL PREPARATION FOR COLONOSCOPY: COMPARISON BETWEEN DIFFERENT TOOLS AND DIFFERENT HEALTHCARE PROFESSIONALS

P.15.9 PRELIMINARY DATA ON SAFETY, EFFICACY AND TOLERABILITY OF BOWEL PREPARATION FOR COLONOSCOPY IN IBD

Measuring disease activity in Crohn's disease: what is currently available to the clinician

P.54 CMV SPECIFIC T-CELL RESPONSE IS CONSERVED IN IBD PATIENTS

P.07.8 MAGNETIZATION TRANSFER IMAGING FOR THE ASSESSMENT OF INTESTINAL FIBROSIS IN CROHN'S DISEASE

NON-INVASIVE MARKERS IN THE ASSESSMENT OF CHRONIC DIARRHOEA

P.02.24 EVALUATION OF QUALITY OF LIFE IN IBD PATIENTS TREATED WITH ANTI-TNFA THERAPY

DETERMINATION OF 5-ASA AND ITS DERIVATIVES IN THE COLONIC MUCOSA OF ULCERATIVE COLITIS PATIENTS: A SURROGATE MARKER OF OXIDATIVE DAMAGE?

ENROLLMENT IN IBD CLINICAL RESEARCH: THE PATIENT'S POINT OF VIEW

P.07.3 EFFECTIVENESS OF GOLIMUMAB IN REAL LIFE – A SINGLE CENTER PROSPECTIVE STUDY

OC.16.5 IMPACT OF ADALIMUMAB'S PATIENT SUPPORT PROGRAM ON ADHERENCE TO ANTI-TNF-ALFA THERAPY IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER ANALYSIS

N014 The impact of nursing care on quality of life in IBD patients: A cross-sectional study

OC.12.6 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1

N010 Impact of adalimumab’s patient support program on adherence to anti-TNFα therapy in patients with inflammatory bowel disease: A single-centre analysis

PC.01.4 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1

Randomized controlled trials in maintenance of remission in Crohn's disease

P506 Efficacy and safety of two bowel preparations for colonoscopy in IBD patients

P701 Cytomegalovirus-specific T-cell response is conserved in IBD patients

P703 A prospective study on Clostridium difficile infection, toxino type and antibiotic sensitivity in inflammatory bowel disease

Suchergebnisse filtern